In October 2012, a maternal pertussis vaccination program was implemented in England following an increased incidence and mortality in infants. We evaluated the cost-effectiveness of the program by comparing pertussis-related infant hospitalizations and deaths in 2012-2017 with nonvaccination scenarios. Despite considerable uncertainties, findings support the cost-effectiveness of the program.
CITATION STYLE
Sandmann, F., Jit, M., Andrews, N., Buckley, H. L., Campbell, H., Ribeiro, S., … Amirthalingam, G. (2020). Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017: Post-implementation Economic Evaluation. Clinical Infectious Diseases, 71(8), 1984–1987. https://doi.org/10.1093/cid/ciaa165
Mendeley helps you to discover research relevant for your work.